Back to Search
Start Over
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy.
- Source :
-
Leukemia research [Leuk Res] 2023 Sep; Vol. 132, pp. 107348. Date of Electronic Publication: 2023 Jun 28. - Publication Year :
- 2023
-
Abstract
- Competing Interests: Declaration of Competing Interest None.
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 132
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Editorial & Opinion
- Accession number :
- 37423073
- Full Text :
- https://doi.org/10.1016/j.leukres.2023.107348